“Baricitinib Achieved Complete Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials”. SKIN The Journal of Cutaneous Medicine 9, no. 1 (January 13, 2025): s520. Accessed October 26, 2025. https://skin.dermsquared.com/skin/article/view/3163.